Taken together, these studies provide the first feasible biochemical mechanism by which the +1166 A/C polymorphism (i.e., miRSNP) can lead to increased hAT1R densities and possibly cardiovascular disease. This evidence concerns the gene AGTR1 and cardiovascular disorder.